Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Psoriasis Treatment Market to Cross USD 40.58 Billion by 2027; Increasing Prevalence of Psoriatic Arthritis to Aid Growth, says Fortune Business Insights(TM)

The global psoriasis treatment market size is projected to reach USD 40.58 billion by the end of 2027. Increasing focus on development of biologics for psoriasis treatment will aid the growth of the overall...

AMGN : 251.66 (+0.03%)
CELGZ : 0.47 (+2.15%)
LLY : 166.45 (-1.58%)
NVS : 87.34 (-0.89%)
PFE : 33.46 (-0.86%)
Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know

Eli Lilly (LLY) closed the most recent trading day at $169.13, moving +1.43% from the previous trading session.

LLY : 166.45 (-1.58%)
Regeneron Initiates Studies on Experimental Coronavirus Drug

Regeneron (REGN) announces initiation of late-stage studies evaluating REGN-COV2 for the treatment and prevention of COVID-19.

REGN : 640.63 (+0.05%)
SNY : 50.55 (-1.88%)
GILD : 74.71 (-1.19%)
LLY : 166.45 (-1.58%)
3 Stocks Bargain Hunters Don't Want to Ignore

Even though the market has almost recovered from its March lows, there is plenty of upside for Eli Lilly and Company (LLY), Novo Nordisk (NVO), and Amgen (AMGN). The market is close to recovering from...

LLY : 166.45 (-1.58%)
NVO : 65.61 (-0.41%)
AMGN : 251.66 (+0.03%)
Here's Why Lilly (LLY) Stock is Up Despite Coronavirus Crisis

Lilly's (LLY) shares are up this year mainly due to rapid progress in its efforts to make medicines/antibodies to treat COVID-19.

RHHBY : 44.5000 (+0.86%)
GILD : 74.71 (-1.19%)
LLY : 166.45 (-1.58%)
ABBV : 97.94 (-1.35%)
4 Solid Stocks to Buy on Renewed Hopes of Coronavirus Vaccine

The past few months have seen pharmaceutical companies making every effort to develop a vaccine for the novel coronavirus.

DVAX : 9.18 (-2.55%)
GILD : 74.71 (-1.19%)
MRNA : 64.97 (+5.51%)
LLY : 166.45 (-1.58%)
GSK : 40.37 (-0.88%)
3 Diverse Stocks to Buy Now for Second Half Coronavirus Immunity & Growth

A look at three stocks from completely different economic sectors that are poised to grow during the second half of 2020, despite continued coronavirus economic uncertainty...

TGT : 117.90 (+0.17%)
AMZN : 3,182.63 (+3.29%)
PFE : 33.46 (-0.86%)
WMT : 127.75 (+2.66%)
DG : 189.74 (+1.72%)
LLY : 166.45 (-1.58%)
NFLX : 507.76 (+0.99%)
TSLA : 1,394.28 (+2.08%)
ABBV : 97.94 (-1.35%)
ZM : 269.52 (+1.20%)
SmarTrend Watching for Potential Pullback in Shares of Eli Lilly & Co After 2.19% Gain

Eli Lilly & Co (NYSE:LLY) traded in a range yesterday that spanned from a low of $164.01 to a high of $168.92. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of...

LLY : 166.45 (-1.58%)
Eli Lilly & Co Rises 2.19% on Heavy Volume: Watch For Potential Pullback

Eli Lilly & Co (NYSE:LLY) traded in a range yesterday that spanned from a low of $164.01 to a high of $168.92. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of...

LLY : 166.45 (-1.58%)
The Zacks Analyst Blog Highlights: Tesla, NVIDIA, Amazon.com, T-Mobile US and Eli Lilly

The Zacks Analyst Blog Highlights: Tesla, NVIDIA, Amazon.com, T-Mobile US and Eli Lilly

NVDA : 420.36 (+2.87%)
AMZN : 3,182.63 (+3.29%)
LLY : 166.45 (-1.58%)
TSLA : 1,394.28 (+2.08%)
TMUS : 106.17 (-0.41%)
4 Reasons to Own AbbVie Stock as Coronavirus Woes Linger

AbbVie's (ABBV) key drug, Humira is seeing strong demand in the United States while generics are eroding ex-U.S. sales. New drugs Skyrizi and Rinvoq are off to a strong start.

JNJ : 142.49 (-0.54%)
RHHBY : 44.5000 (+0.86%)
LLY : 166.45 (-1.58%)
ABBV : 97.94 (-1.35%)
4 Dividend Stocks to Buy if There is a Second Market Crash

The coronavirus has yet to subside in the US and there are fears about a second wave. Oracle (ORCL), Eli Lilly (LLY), EBay (EBAY) and CoreSite Realty (COR) are four dividend stocks that could be a smart...

ORCL : 57.53 (+1.54%)
LLY : 166.45 (-1.58%)
EBAY : 59.22 (+1.63%)
COR : 124.36 (+1.31%)
Johnson & Johnson Gets European Approval for Ebola Vaccine

J&J (JNJ) gets approval from the European Commission for Ebola vaccine.

JNJ : 142.49 (-0.54%)
MRK : 76.69 (-1.58%)
LLY : 166.45 (-1.58%)
ABBV : 97.94 (-1.35%)
4 Top Pharmaceutical Stocks For The Second Half of 2020

Eli Lilly & Co. (LLY), AbbVie Inc. (ABBV), Zoetis Inc. (ZTS) and Neurocrine Biosciences Inc. (NBIX) are stocks that could move significantly higher in the second half of this year. Pharmaceutical...

LLY : 166.45 (-1.58%)
ABBV : 97.94 (-1.35%)
ZTS : 137.68 (-0.81%)
NBIX : 131.56 (+1.11%)
Massive Shift in Practice Patterns in Psoriatic Arthritis as Rheumatologists Lean Toward Increased Use of JAK inhibitors and Novel Biologics

, /PRNewswire/ -- Over the past four years, multiple new agents have been FDA approved for the treatment of psoriatic arthritis (PsA), including Pfizer's Xeljanz, Eli Lilly's Taltz, BMS' Orencia, and...

LLY : 166.45 (-1.58%)
Pandemic Fails to Deter YTD Rally of These Top 5 US Behemoths

A handful of corporate behemoths has skyrocketed YTD. Some of these stocks carry a favorable Zacks Rank and have rallied more than 20% YTD.

NVDA : 420.36 (+2.87%)
AMZN : 3,182.63 (+3.29%)
LLY : 166.45 (-1.58%)
TSLA : 1,394.28 (+2.08%)
TMUS : 106.17 (-0.41%)
Buy Pharma Giant AbbVie Stock for Growth, Income & Coronavirus Safety

All of this might make investors want to consider AbbVie for the second half of 2020 with coronavirus fears and volatility likely to linger...

PFE : 33.46 (-0.86%)
MRK : 76.69 (-1.58%)
LLY : 166.45 (-1.58%)
ABBV : 97.94 (-1.35%)
Global Autoimmune Disease Diagnostics Market By Type, By Sex, By Age, By Factors, By Diagnosis, By Types of Treatment, By Product, By End-User, By Region, Competition, Forecast & Opportunities, 2025

, /PRNewswire/ -- Read the full report: Global autoimmune disease diagnostics market size was valued at in 2019 and projected to grow at a formidable CAGR during the forecast period.The key factor...

LLY : 166.45 (-1.58%)
SIEGY : 59.9500 (-1.09%)
The Zacks Analyst Blog Highlights: Visa, JPMorgan Chase, Bank of America, Chevron and Eli Lilly

The Zacks Analyst Blog Highlights: Visa, JPMorgan Chase, Bank of America, Chevron and Eli Lilly

JPM : 91.28 (-2.17%)
BAC : 22.77 (-1.43%)
CVX : 82.74 (-4.18%)
LLY : 166.45 (-1.58%)
V : 192.21 (-1.47%)
QurAlis Announces Agreement to Strengthen ALS Pipeline

QurAlis Corporation, a biotech company focused on developing precision medicines for amyotrophic lateral sclerosis (ALS) and other neurologic diseases, today announced an agreement to in-license pre-clinical...

LLY : 166.45 (-1.58%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS +1.37 , SEDG -0.74 , THC -0.92 , TER +0.71 , LITE +1.63
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar